000			02222 a2200637 4500
005			20250516070046.0
264		0	_c20120416
008			201204s 0 0 eng d
022			_a1432-1335
024	7		_a10.1007/s00432-011-1103-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Li-E
245	0	0	_aRoles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. _h[electronic resource]
260			_bJournal of cancer research and clinical oncology _cMar 2012
300			_a377-85 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aCase-Control Studies
650	0	4	_aClass I Phosphatidylinositol 3-Kinases
650	0	4	_aEndometrial Neoplasms _xgenetics
650	0	4	_aFemale
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLogistic Models
650	0	4	_aMiddle Aged
650	0	4	_aOdds Ratio
650	0	4	_aPTEN Phosphohydrolase _xgenetics
650	0	4	_aPhosphatidylinositol 3-Kinases _xgenetics
650	0	4	_aPilot Projects
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aProportional Hazards Models
650	0	4	_aProto-Oncogene Proteins c-akt _xgenetics
650	0	4	_aProto-Oncogene Proteins p21(ras) _xgenetics
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aSignal Transduction _xgenetics
650	0	4	_aTOR Serine-Threonine Kinases _xgenetics
650	0	4	_aTreatment Outcome
650	0	4	_araf Kinases _xgenetics
700	1		_aMa, Hongxia
700	1		_aHale, Katherine S
700	1		_aYin, Ming
700	1		_aMeyer, Larissa A
700	1		_aLiu, Hongliang
700	1		_aLi, Jie
700	1		_aLu, Karen H
700	1		_aHennessy, Bryan T
700	1		_aLi, Xuesong
700	1		_aSpitz, Margaret R
700	1		_aWei, Qingyi
700	1		_aMills, Gordon B
773	0		_tJournal of cancer research and clinical oncology _gvol. 138 _gno. 3 _gp. 377-85
856	4	0	_uhttps://doi.org/10.1007/s00432-011-1103-0 _zAvailable from publisher's website
999			_c21370840 _d21370840